What is the address of DR. JAN MIEVIS?

The registered office of DR. JAN MIEVIS is located at Riddersstraat 39, 3890 Gingelom.

Is DR. JAN MIEVIS still active?

Yes. According to the CBE (30 October 2026) DR. JAN MIEVIS is active, legal situation “Normale toestand”, started on 26 May 2020.

Is DR. JAN MIEVIS registered on Peppol?

Yes, DR. JAN MIEVIS is registered on the Peppol network with ID 0208:0747613048.

What is the enterprise number of DR. JAN MIEVIS?

The enterprise number of DR. JAN MIEVIS is BE0747613048.

When was DR. JAN MIEVIS founded?

DR. JAN MIEVIS was founded on 26 May 2020.

Who are the directors of DR. JAN MIEVIS?

According to the 2025 annual accounts, the directors of DR. JAN MIEVIS are: Jan Mievis.

Is DR. JAN MIEVIS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 May 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. JAN MIEVIS make in 2025?

DR. JAN MIEVIS posted a profit after taxes of € 212,037 in financial year 2025.

What is the revenue of DR. JAN MIEVIS?

As a small company, DR. JAN MIEVIS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 360,416.

DR. JAN MIEVIS (Private Limited) - Gingelom

Dossier DR. JAN MIEVIS, printed on 30 October 2026 from databakkes.be/en/0747613048/dr-jan-mievis. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. JAN MIEVIS from Gingelom, company number BE0747613048, closed financial year 2025 with a result of € 212,037 after tax. For that financial year DR. JAN MIEVIS recorded a gross margin of € 360,416 and equity of € 409,246. Compared with financial year 2024, the result moved from € 215,100 to € 212,037. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.

What it is worth Healthy

€ 409,246

▼ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 212,037

▼ 1% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 262,867

▲ 2% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 215,100 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 2,928

▼ 32% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 97,724

▼ 40% vs 2024

€ 65,070 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 582

▲ € 497 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 1,731

▼ 75% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 288,122 Gross margin 2022: € 288,122 First fiscal year in the series	€ 350,000 Gross margin 2023: € 350,000 ▲ 21% vs 2022 (€ 288,122) Favourable step	€ 345,329 Gross margin 2024: € 345,329 ▼ 1% vs 2023 (€ 350,000) Unfavourable step	€ 360,416 Gross margin 2025: € 360,416 ▲ 4% vs 2024 (€ 345,329) Favourable step	▲ 4%
Profit after taxes	€ 171,484 Profit after taxes 2022: € 171,484 First fiscal year in the series	€ 222,194 Profit after taxes 2023: € 222,194 ▲ 30% vs 2022 (€ 171,484) Favourable step	€ 215,100 Profit after taxes 2024: € 215,100 ▼ 3% vs 2023 (€ 222,194) Unfavourable step	€ 212,037 Profit after taxes 2025: € 212,037 ▼ 1% vs 2024 (€ 215,100) Unfavourable step	▼ 1%
Equity	€ 368,693 Equity 2022: € 368,693 First fiscal year in the series	€ 590,886 Equity 2023: € 590,886 ▲ 60% vs 2022 (€ 368,693) Favourable step	€ 412,308 Equity 2024: € 412,308 ▼ 30% vs 2023 (€ 590,886) Unfavourable step	€ 409,246 Equity 2025: € 409,246 ▼ 1% vs 2024 (€ 412,308) Unfavourable step	▼ 1%
Total debts	€ 342,480 Total debts 2022: € 342,480 First fiscal year in the series	€ 271,250 Total debts 2023: € 271,250 ▼ 21% vs 2022 (€ 342,480) Favourable step	€ 553,639 Total debts 2024: € 553,639 ▲ 104% vs 2023 (€ 271,250) Unfavourable step	€ 691,755 Total debts 2025: € 691,755 ▲ 25% vs 2024 (€ 553,639) Unfavourable step	▲ 25%
Cash	€ 186,522 Cash 2022: € 186,522 First fiscal year in the series	€ 30,550 Cash 2023: € 30,550 ▼ 84% vs 2022 (€ 186,522) Unfavourable step	€ 258,283 Cash 2024: € 258,283 ▲ € 227,732 vs 2023 (€ 30,550) Favourable step	€ 262,867 Cash 2025: € 262,867 ▲ 2% vs 2024 (€ 258,283) Favourable step	▲ 2%
Retained profit	€ 358,693 Retained profit 2022: € 358,693 First fiscal year in the series	€ 580,886 Retained profit 2023: € 580,886 ▲ 62% vs 2022 (€ 358,693) Favourable step	€ 402,308 Retained profit 2024: € 402,308 ▼ 31% vs 2023 (€ 580,886) Unfavourable step	€ 399,246 Retained profit 2025: € 399,246 ▼ 1% vs 2024 (€ 402,308) Unfavourable step	▼ 1%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 393,678 Dividend 2024: € 393,678 Unchanged (€ 0) Unchanged	€ 215,100 Dividend 2025: € 215,100 ▼ 45% vs 2024 (€ 393,678) Unchanged	▼ 45%
Bank debt	€ 291,043 Bank debt 2022: € 291,043 First fiscal year in the series	€ 226,916 Bank debt 2023: € 226,916 ▼ 22% vs 2022 (€ 291,043) Favourable step	€ 162,479 Bank debt 2024: € 162,479 ▼ 28% vs 2023 (€ 226,916) Favourable step	€ 97,724 Bank debt 2025: € 97,724 ▼ 40% vs 2024 (€ 162,479) Favourable step	▼ 40%
Balance sheet total	€ 711,173 Balance sheet total 2022: € 711,173 First fiscal year in the series	€ 862,136 Balance sheet total 2023: € 862,136 ▲ 21% vs 2022 (€ 711,173) Unchanged	€ 965,947 Balance sheet total 2024: € 965,947 ▲ 12% vs 2023 (€ 862,136) Unchanged	€ 1,101,000 Balance sheet total 2025: € 1,101,000 ▲ 14% vs 2024 (€ 965,947) Unchanged	▲ 14%

Key figures of DR. JAN MIEVIS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. JAN MIEVIS?

What happened at DR. JAN MIEVIS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 6, 2026 New annual accounts for financial year 2025: profit of € 212,037 (▼ 1% vs 2024). Source: NBB ↗
May 26, 2020 New establishment in Gingelom. KBO
May 26, 2020 Start of the company according to the CBE. KBO

In short

From € 171,484 profit in 2022 to € 212,037 profit in 2025.

Paid € 255,695 in corporate taxes since 2022.

Best year ever: 2023, with € 222,194 profit.

Paid out € 608,778 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Jan Mievis

DR. JAN MIEVIS

Orthoteam Limburg

Behind DR. JAN MIEVIS is Jan Mievis. Jan Mievis is also behind Orthoteam Limburg.

Directors

According to the 2025 annual accounts

Jan Mievis

Director

Also active at: Orthoteam Limburg

Establishments

Establishment units

Physical locations of this company

Registered office

Riddersstraat 39

3890 Gingelom

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

VAJ INVEST

€ 271,706 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0747.613.048
VAT number: BE 0747.613.048
Registered office: Riddersstraat 39, 3890 Gingelom
Names & denominations: DR. JAN MIEVIS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 26 May 2020
Peppol: Active · Active since 1 Jan 2001

View on CBE Public ↗ Annual accounts (NBB) ↗